Botulinum A exotoxin in clinical ophthalmology.
Carruthers
J D
JD
Department of Ophthalmology, University of British Columbia, Vancouver.
Carruthers
A
A
D000818:Animals; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004576:Electromyography; D005152:Facial Muscles / Q000187:drug effects / Q000294:innervation / Q000503:physiopathology; D006801:Humans; D009121:Muscle Denervation / Q000379:methods; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D015835:Ocular Motility Disorders / Q000188:drug therapy* / Q000503:physiopathology; D009801:Oculomotor Muscles / Q000187:drug effects / Q000294:innervation / Q000503:physiopathology
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A